CVC Leadership
The CVC Scientific Advisory Committee, composed of a diverse group of renowned clinical immunologists from the world's top institutions, guides the Clinical Accelerator's scientific strategy and clinical trial selection.
The CVC Management Team, which includes key executives from both CRI and the Ludwig Institute, is responsible for a) the CVC's year-round operations and administration, b) facilitating scientific discussions among CVC members, and c) the program's investment, intellectual property, clinical trial, and biopharma partnership managements.
CVC Scientific Advisory Committee
-
Jedd D. Wolchok, M.D., Ph.D.
Memorial Sloan-Kettering Cancer Center, and Ludwig Institute for Cancer Research
-
Jonathan Cebon, Ph.D., FRACP
Ludwig Institute for Cancer Research, Austin Health
-
Glenn Dranoff, M.D.
Dana-Farber Cancer Institute, Harvard Medical School
-
Alexander Knuth, M.D.
University Hospital Zurich
-
Kunle Odunsi, M.D., Ph.D.
Roswell Park Cancer Institute
-
Craig L. Slingluff Jr., M.D.
University of Virginia School of Medicine
CVC Management Team